Treatment works. The disease stops spreading after the first dose.
Every January, Brazil wraps a purple ribbon around a wound that medicine has largely healed but society has not. Hansen's disease — curable, treatable, no longer contagious after a single dose of antibiotics — persists in Brazil at a rate second only to India's, accounting for nine in ten cases across the Americas, because the true contagion is not bacterial but cultural: fear, misinformation, and a stigma older than the nation itself. In Ceará alone, nearly twelve thousand people were diagnosed between 2015 and 2022, including hundreds of children, each one a reminder that silence and shame are as disabling as any nerve damage. The Janeiro Roxo campaign asks not merely that people remember the disease, but that they unlearn the ancient dread that keeps its sufferers invisible.
- Brazil carries the second-highest Hansen's disease burden on earth, yet most Brazilians still associate the illness with medieval horror rather than a curable bacterial infection treatable with free antibiotics.
- In Ceará, 11,727 cases were recorded in just seven years — 486 of them in children under fifteen — concentrated in major cities where the disease is present and visible yet rarely spoken about openly.
- The cruelest irony driving the campaign's urgency: patients stop being contagious after their very first dose of treatment, meaning the isolation and exclusion they face is built entirely on outdated fear.
- Nurse and advocate Verônica Gurgel describes fighting myths that refuse to die — that the disease spreads easily, that it is incurable, that those who carry it must be kept apart — myths that cause more lasting harm than the bacterium itself.
- The Janeiro Roxo campaign, anchored by the purple ribbon and backed by the WHO, is pushing a deceptively simple counter-narrative: Hansen's disease is curable, its patients are not dangerous, and dignity is not a privilege reserved for the healthy.
Every January, Brazil turns its attention to a disease most people would rather forget. The purple ribbon campaign marks the month dedicated to Hansen's disease — a bacterial infection that has shadowed human history for centuries, leaving behind not just physical scars but deep wells of shame. The disease is treatable, even curable. The real problem is everything else.
Brazil ranks second globally in Hansen's disease cases, trailing only India, and accounts for 90 percent of all cases reported across the Americas. In Ceará alone, health authorities documented 11,727 cases between 2015 and 2022, including 486 children under fifteen. The infection is caused by Mycobacterium leprae, identified in 1873 by Norwegian physician Armauer Hansen. The name 'leprosy' carried such biblical dread that a Brazilian dermatologist pushed to rename it in 1976, understanding that language shapes how society treats the people who carry a disease. The new name has only partially succeeded in stripping away the stigma.
The disease moves slowly — symptoms can take two to seven years to appear — and announces itself through numb skin patches, tingling nerves, hair loss, and swelling. Left untreated, it destroys nerves, weakens muscles, steals vision, and leaves people unable to feel their own hands and feet. Some go blind. Some become permanently disabled. Yet modern medicine has solved the biological problem: a course of free antibiotics lasting six to twelve months cures the disease entirely, and patients stop transmitting it after the very first dose.
Knowledge of these facts remains dangerously sparse. Verônica Gurgel, a nurse coordinating Hansen's disease reintegration efforts in Fortaleza, describes fighting myths that refuse to die — that the disease is incurable, that it spreads easily, that those who carry it must be isolated. In Ceará, seven cities including Fortaleza, Sobral, and Juazeiro do Norte account for sixty percent of the state's cases. These are not remote places. The disease is present and real, yet the conversation about it remains muted by shame.
The Janeiro Roxo campaign carries a message both simple and radical: Hansen's disease exists, it is treatable, and the people living with it deserve dignity rather than exile. It is a campaign against forgetting — but more precisely, against the kind of remembering that has always done more damage than the bacterium itself.
Every January, Brazil turns its attention to a disease most people would rather forget. The purple ribbon campaign arrives quietly, marking the month dedicated to Hansen's disease—a bacterial infection that has shadowed human history for centuries, leaving behind not just physical scars but deep wells of shame and isolation. The disease itself is treatable, even curable. The real problem is everything else: the ignorance that surrounds it, the fear it generates, the way it still marks people as untouchable in a country that should know better.
Brazil carries a particular burden in this fight. According to the World Health Organization, the nation ranks second globally in Hansen's disease cases, trailing only India. More striking still: Brazil accounts for 90 percent of all cases reported across the entire Americas. In the state of Ceará alone, between 2015 and 2022, health authorities documented 11,727 cases. Among those were 486 children under fifteen years old. The disease does not discriminate by age, though men account for roughly 55 percent of cases, and people between fifty and sixty bear the heaviest load.
The infection itself is caused by a bacterium called Mycobacterium leprae, discovered in 1873 by the Norwegian physician Armauer Hansen. For decades it was called leprosy—a word so laden with biblical dread and medieval horror that in 1976, a Brazilian dermatologist named Abrahão Rotberg pushed to change the name entirely. He understood that language shapes how we see disease, and how we see disease shapes how we treat the people who carry it. The new name, Hansen's disease, was meant to strip away centuries of stigma. It has only partially succeeded.
The disease moves slowly through the body. It can take two to seven years for the first symptoms to appear after infection. When they do, they announce themselves in ways both subtle and devastating: pale or reddish patches on the skin that feel numb to touch, a loss of sensation to heat and pain, tingling along nerve pathways, hair falling out in patches, swelling in the hands and feet. If left untreated, the damage compounds. Nerves thicken and weaken. Muscles atrophy. Vision blurs and fails. People lose the ability to feel their own hands and feet, leading to burns and wounds they cannot sense. Some go blind. Some become permanently disabled, unable to work, unable to live without assistance.
Yet here is the paradox that makes the stigma so cruel: the disease is curable. Modern medicine has solved the biological problem. Treatment consists of antibiotics distributed free through Brazil's public health system. The course lasts between six months and a year. More importantly, patients stop transmitting the disease after taking the very first dose. They are no longer contagious. They can return to their homes, their workplaces, their families without risk. And if treatment begins early enough, before nerve damage becomes severe, people can be cured without any lasting disability at all.
But knowledge of these facts remains sparse. Verônica Gurgel, a nurse who coordinates the Movement for the Reintegration of People Affected by Hansen's Disease in Fortaleza, speaks with the weariness of someone fighting an uphill battle against ignorance. She explains that many people still believe the old myths: that the disease is incurable, that it spreads easily, that those who have it must be isolated. They do not know that transmission requires prolonged contact with an untreated person in an advanced stage of infection. They do not know that treatment works. They do not know that their fear is based on outdated information and ancient prejudice.
In Ceará, seven municipalities—Iguatu, Sobral, Juazeiro do Norte, Crato, Maracanaú, Fortaleza, and Caucaia—account for sixty percent of the state's cases, placing Ceará fourth among northeastern states in disease prevalence. These are not remote areas. These are cities where people live and work and go to school. The disease is present, visible, real. And yet the conversation about it remains muted, shadowed by shame.
The campaign launched in January, marked by the purple ribbon, carries a simple message: do not forget Hansen's disease. Do not forget that it exists, that it is treatable, that people living with it deserve dignity and inclusion, not exile. The message comes from Yohei Sasakawa, a goodwill ambassador for the World Health Organization, and it echoes through organizations like Morhan, which works to reintegrate people into society after treatment. It is a campaign against forgetting, yes—but also against the particular kind of remembering that poisons everything it touches.
Notable Quotes
The lack of knowledge about the disease is frequent, leading to fear and prejudice. People don't know that once treatment begins, there is no more risk of transmission, and the person can live normally at home, at work, and with friends.— Dr. Araci Pontes, dermatologist at Centro de Dermatologia Dona Libânia
The disease is characterized by loss of sensation and muscle weakness, mainly in hands, arms, feet, legs, and eyes. When untreated, it causes permanent deformities and irreversible disabilities.— Verônica Gurgel, coordinator of the Movement for Reintegration of People Affected by Hansen's Disease in Fortaleza
The Hearth Conversation Another angle on the story
Why does a disease that's curable still carry so much shame in Brazil?
Because the shame predates the cure. For centuries, leprosy—as it was called—meant exile, disfigurement, death. That weight doesn't disappear just because antibiotics were invented. The word itself had to be changed to begin breaking the spell.
But if treatment works so well, why are there still nearly twelve thousand cases in Ceará alone?
Because knowing a cure exists and actually accessing it are different things. And because people don't seek treatment if they don't know they have the disease, or if they're too afraid of what it means to admit it.
What's the most dangerous misconception people have?
That it spreads easily, that you catch it from casual contact. The truth is far more specific—you need prolonged exposure to someone who's untreated and in an advanced stage. But that nuance gets lost. Fear doesn't do nuance.
The children under fifteen—how does a child get this disease?
Usually from a family member who hasn't been diagnosed yet. Which means the disease is hiding in households, spreading quietly, because no one recognized the early signs.
And once someone starts treatment?
They stop being contagious immediately. After the first dose. They can go back to work, to school, to their family. But how many people know that? How many employers would hire someone they believe carries leprosy, even if it's no longer true?
So the real disease is the stigma.
The disease itself can be cured in a year. The stigma has been incurable for a thousand years.